Clinical trial
An Open-label, Multi-center Study to Evaluate the Efficacy and Safety of Statin-fenofibrate Combination Therapy in Dyslipidemic Chinese Patients
NCT01462877 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Multi-center Study to Evaluate the Efficacy and Safety of Statin-fenofibrate Combination Therapy in Dyslipidemic Chinese Patients
- Lead sponsor
- Abbott
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2011
- Completion date
- March 31, 2014
- Enrollment
- 506 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.